News

The MAPLe is effective for OAB

25 Nov 2016

The MAPLe® is effective for OAB The Medical journal Neurourology and Urodynamics published a clinical study on the treatment of overactive bladder (OAB) sydrome with the MAPLe.The study, performed und...

Learn more

The MAPLe® wins the award for the most innovative medical device during the MEDICA

23 Nov 2016

The MAPLe® wins the award for the most innovative medical device during the MEDICA in Düsseldorf (Germany) The MEDICA in Düsseldorf – this year from 14-18 November – is the world’s leading trade fair ...

Learn more

MAPLe case study: Defecation while running

2 Sep 2016

The patient is a woman of 46, who started running three years ago. After three quarters of an hour of running she gets urgency feelings and some stool also leaks out.Seven years ago she gave birth wit...

Learn more

Innovative developments at the IMPRESS Symposium 2016

1 Jul 2016

On Monday, 20 June 2016 Novuqare was a guest speaker at the IMPRESS Symposium 2016: Next Generation Technologies in Leeds. About 60 attendees listened attentively to the latest developments in the fie...

Learn more

Male, 46 years, has anal pain and difficulty emptying the bowel

17 Jun 2016

Man, 46 years old, a sedentary occupation, suffers from anal pain especially during defecation, with pain that continues for a long period thereafter. Evacuation is laborious during defecation and he ...

Learn more

Tendim officially became a certified MAPLe distributor!

6 Jun 2016

We are delighted that on 3 June, Tendim officially became a certified MAPLe distributor! Tendim is a Belgian supplier of medical and paramedical products for - among others - physiotherapists. Karel V...

Learn more

Contact form Send an e-mail

Terms and Conditions Novuqare Pelvic Health B.V.

Privacy Statement

Working for Novuqare